FACTORS THAT DIFFERENTLY ASSOCIATE WITH THE RETENTION ON TARGETED THERAPY OF PATIENTS WITH RHEUMATOID ARTHRITIS

被引:0
|
作者
Zhilyaev, E. [1 ,2 ]
Lukina, G. [3 ]
Koltsova, E. [3 ,4 ]
Lytkina, K. [5 ]
Shmidt, E. [6 ]
机构
[1] European Med Ctr, Med Derect, Moscow, Russia
[2] Russian Med Acad Continous Profess Educ, Rheumatol, Moscow, Russia
[3] AS Loginov Moscow Clin Sci Ctr, Rheumatol, Moscow, Russia
[4] Res Inst Org Hlth & Healthcare Managment Org & Me, Dept Rheumatol, Moscow, Russia
[5] City Clin Hosp, Rheumatol, Moscow, Russia
[6] NI Pirogov City Clin Hosp, Rheumatol, Moscow, Russia
关键词
D O I
10.1136/annrheumdis-2021-eular.3953
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0241
引用
收藏
页码:1146 / 1146
页数:1
相关论文
共 50 条
  • [41] Mitochondrial Dysfunction Affects the Synovium of Patients with Rheumatoid Arthritis and Osteoarthritis Differently
    Javor, Peter
    Macsai, Attila
    Butt, Edina
    Barath, Balint
    Jasz, David Kurszan
    Horvath, Tamara
    Barath, Bence
    Csonka, Akos
    Torok, Laszlo
    Varga, Endre
    Hartmann, Petra
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (14)
  • [42] Utilization of Biologic and Targeted Disease Modifying Antirheumatic Therapy in Patients with Rheumatoid Arthritis and Breast Cancer
    Ruiz, Juan
    Wu, Chi-Fang
    Zhao, Hui
    Giordano, Sharon
    Rajan, Suja
    Suarez-Almazor, Maria
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 139 - 140
  • [43] Criteria for TNF-Targeted therapy in rheumatoid arthritis - Estimates of the number of patients potentially eligible
    Kvien, TK
    Uhlig, T
    Kristiansen, IS
    DRUGS, 2001, 61 (12) : 1711 - 1720
  • [44] Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis After a Change in Targeted Therapy
    Bonafede, Machaon M. K.
    McMorrow, Donna
    Proudfoot, Clare
    Shinde, Shraddha
    Kuznik, Andreas
    Chen, Chieh-I
    AMERICAN HEALTH AND DRUG BENEFITS, 2018, 11 (04): : 192 - 202
  • [45] ETANERCEPT RETENTION RATES IN PATIENTS WITH RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS OR PSORIATIC ARTHRITIS
    Dongen, C. V.
    Kneepkens, E.
    Vogelzang, E.
    l'Ami, M.
    Krieckaert, C.
    van der Horst, I.
    Voskuyl, A.
    Nurmohamed, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1145 - 1145
  • [46] RETENTION OF Y-90 IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    RAMSEY, NW
    ANNALS OF THE RHEUMATIC DISEASES, 1973, 32 (06) : 38 - 40
  • [47] Drug Retention Rate of Oral Bisphosphonate in Patients with Rheumatoid Arthritis
    Park, Ji-Heh
    Lee, Seung-Geun
    Park, Eun-Kyoung
    Tag, Hee-Sang
    Kim, Geun-Tae
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [48] Factors affecting drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study
    Kosuke Ebina
    Toru Hirano
    Yuichi Maeda
    Wataru Yamamoto
    Motomu Hashimoto
    Koichi Murata
    Akira Onishi
    Sadao Jinno
    Ryota Hara
    Yonsu Son
    Hideki Amuro
    Tohru Takeuchi
    Ayaka Yoshikawa
    Masaki Katayama
    Keiichi Yamamoto
    Yasutaka Okita
    Makoto Hirao
    Yuki Etani
    Atsushi Kumanogoh
    Seiji Okada
    Ken Nakata
    Scientific Reports, 12
  • [49] Factors affecting drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study
    Ebina, Kosuke
    Hirano, Toru
    Maeda, Yuichi
    Yamamoto, Wataru
    Hashimoto, Motomu
    Murata, Koichi
    Onishi, Akira
    Jinno, Sadao
    Hara, Ryota
    Son, Yonsu
    Amuro, Hideki
    Takeuchi, Tohru
    Yoshikawa, Ayaka
    Katayama, Masaki
    Yamamoto, Keiichi
    Okita, Yasutaka
    Hirao, Makoto
    Etani, Yuki
    Kumanogoh, Atsushi
    Okada, Seiji
    Nakata, Ken
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [50] Influential factors in the continuity of basic therapy for rheumatoid arthritis
    Listing, J
    Zink, A
    Brauer, D
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 1998, 57 (04): : 246 - 247